已收盘 11-13 16:00:00 美东时间
-0.220
-1.53%
Crescent Biopharma (NASDAQ:CBIO) reported quarterly losses of $(0.90) per share which missed the analyst consensus estimate of $(0.72) by 25 percent. This is a 29.13 percent increase over losses of $(1.27) per share from the same period last year. The company reported quarterly sales of $3.117 milli...
11-13 05:37
Crescent Biopharma announced progress in its clinical trials, including completing dose escalation for CR-001 in the ASCEND trial and initiating the APOLLO trial for CR-002. The company achieved nine IND clearances with partner Kelun-Biotech and expects to dose over 2,000 patients by mid-2027. Financial results showed a cash position of $289.4 million, with plans to advance multiple combination therapies and expand clinical development.
11-12 21:15
BIO-key® International, Inc. has been selected by a major U.S. casino resort to deploy its PortalGuard® IAM platform and Identity-Bound Biometrics (IBB) to secure workforce access across its 24/7 gaming and hospitality operations. This enterprise-wide deployment marks BIO-key's entry into the gaming and hospitality industry. The solution addresses challenges such as shared workstations, restricted mobile device use, and the need for quick, secure...
11-11 13:27
Netskope appoints Carrie Francey as Senior Vice President of Global Channel Sales, tasked with driving its partner-led growth strategy in the cloud, AI, and security landscape. Francey, with a career spanning leadership roles at HPE, Microsoft, ServiceNow, and Zendesk, will oversee Netskope’s global partner ecosystem, including MSPs, MSSPs, cloud marketplaces, and GSIs. She aims to deepen collaborations, expand market reach, and deliver modern se...
11-10 14:00
AI sales group Nooks has secured a $500 million funding commitment from General...
11-04 20:41
An update from Catalyst Metals Limited ( ($AU:CYL) ) is now available. Catalyst...
11-04 07:20
<p>Crescent Biopharma, a clinical-stage biotechnology company focused on advancing cancer therapies, announced that its independent Compensation Committee approved the grant of options to purchase 11,775 shares of the Company’s ordinary shares to a non-executive employee under the 2025 Inducement Plan. The options, approved on November 2, 2026, have a 10-year term with an exercise price of $12.91, the closing price on the grant date. They vest as...
11-03 21:15
Prenetics Global Limited announced that Brian J. Rosin will succeed Stephen Lo as Chief Financial Officer, effective December 31, 2026. Rosin, who joined as CFO of IM8 in May 2026, will lead the Company's global finance organization. Prenetics' finance leadership is now based in the United States, aligning with its largest market. Stephen Lo will transition to a Senior Advisor role. The Company will report third-quarter 2026 results on November 1...
11-03 14:05
Envoy expands to Southwest Florida, launching on-site EV car-sharing at Montage at Midtown, a 321-unit residential community in Fort Myers. Residents can reserve Tesla Model 3 vehicles by the hour or day via the Envoy Mobility app. This service provides convenient access to electric vehicles without ownership costs, offering flexibility for residents and enhancing property amenities. Envoy's "Mobility as an Amenity®" platform manages vehicle oper...
11-03 12:00
UBS analyst Al Harvey maintained a Buy rating on Catalyst Metals Limited today ...
11-02 08:35